INVO BioScience, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1283985,
    "name": "INVO BioScience, Inc.",
    "stock_name": "INVO BioScience, Inc.",
    "full_name": "INVO BioScience, Inc.",
    "name_url": "stocks-analysis/invo-bioscience-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "1.64",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "1.64",
    "mcapval": "0.94",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US44984F4019",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "153.32 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/invo-bioscience-inc-1283985-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is INVO BioScience, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-invo-bioscience-inc-technically-bullish-or-bearish-3546910",
        "imagepath": "",
        "date": "2025-09-20 19:42:53",
        "description": "As of 26 August 2025, the technical trend for INVO BioScience, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and the Bollinger Bands, both reflecting bearish signals. The weekly and monthly MACD readings are mildly bullish, but they are overshadowed by the bearish signals from the KST and Dow Theory on a monthly basis. The stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -97.01% versus the S&P 500's 12.22%...."
      },
      {
        "title": "Is INVO BioScience, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-invo-bioscience-inc-overvalued-or-undervalued-3543390",
        "imagepath": "",
        "date": "2025-09-20 18:18:05",
        "description": "As of 15 May 2023, the valuation grade for INVO BioScience, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its significant losses, as evidenced by a Price to Book Value of 0.13, an EV to EBIT of -0.75, and an EV to EBITDA of -0.83. In comparison to peers, NanoVibronix, Inc. has a more pronounced EV to EBITDA of -0.2892, while Nuwellis, Inc. shows an EV to EBIT of -0.2109, suggesting that INVO BioScience is lagging behind its competitors in terms of valuation metrics.\n\nFurthermore, the company's stock performance has been dismal, with a year-to-date return of -97.01%, starkly contrasting with the S&P 500's positive return of 12.22% during the same period. This dramatic underperformance reinforces the notion that INVO BioScience is overvalued in its current state...."
      }
    ],
    "total": 6,
    "sid": "1283985",
    "stock_news_url": "https://www.marketsmojo.com/news/invo-bioscience-inc-1283985"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is INVO BioScience, Inc. technically bullish or bearish?

2025-09-20 19:42:53

As of 26 August 2025, the technical trend for INVO BioScience, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and the Bollinger Bands, both reflecting bearish signals. The weekly and monthly MACD readings are mildly bullish, but they are overshadowed by the bearish signals from the KST and Dow Theory on a monthly basis. The stock has significantly underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -97.01% versus the S&P 500's 12.22%....

Is INVO BioScience, Inc. overvalued or undervalued?

2025-09-20 18:18:05

As of 15 May 2023, the valuation grade for INVO BioScience, Inc. has moved from does not qualify to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its significant losses, as evidenced by a Price to Book Value of 0.13, an EV to EBIT of -0.75, and an EV to EBITDA of -0.83. In comparison to peers, NanoVibronix, Inc. has a more pronounced EV to EBITDA of -0.2892, while Nuwellis, Inc. shows an EV to EBIT of -0.2109, suggesting that INVO BioScience is lagging behind its competitors in terms of valuation metrics. Furthermore, the company's stock performance has been dismal, with a year-to-date return of -97.01%, starkly contrasting with the S&P 500's positive return of 12.22% during the same period. This dramatic underperformance reinforces the notion that INVO BioScience is overvalued in its current state....

View All News